Management of Lactic Acidosis
The primary treatment for lactic acidosis is to identify and address the underlying cause, with specific interventions determined by the type of lactic acidosis (Type A or Type B). 1
Types of Lactic Acidosis and Initial Management
Type A (Hypoxic) Lactic Acidosis
- Caused by tissue hypoperfusion and hypoxia
- Management priorities:
- Restore adequate tissue perfusion and oxygen delivery
- Treat underlying causes: sepsis, shock, cardiac failure, respiratory failure
- For sepsis-induced lactic acidosis: early antibiotics and source control 1
Type B (Non-hypoxic) Lactic Acidosis
- Occurs without evidence of tissue hypoxia
- Management priorities:
Diagnostic Criteria
- Blood pH < 7.35
- Elevated blood lactate levels (> 5 mmol/L)
- Anion gap acidosis
- Increased lactate:pyruvate ratio 1
Specific Management Approaches
Fluid Resuscitation and Hemodynamic Support
- Correct hypovolemia to improve tissue perfusion
- Ensure adequate oxygen delivery
- Monitor hemodynamics and cardiac rhythm 1
Medication Management
- Immediately discontinue medications associated with lactic acidosis:
Bicarbonate Therapy
- Generally not recommended for routine treatment of lactic acidosis
- May be considered when pH < 7.15 with hemodynamic instability
- Monitor for complications: hypocalcemia, volume overload, paradoxical intracellular acidosis 1, 3
Renal Replacement Therapy
- Indications:
- Hemodialysis is particularly effective for metformin-associated lactic acidosis as metformin is dialyzable (clearance up to 170 mL/min) 2
Electrolyte Management
- Monitor and correct electrolyte abnormalities:
- Potassium (if < 3.5 mmol/L): 0.25 mmol/kg over 30 min
- Total calcium (if < 2 mmol/L): 0.3 ml/kg 10% Ca gluconate over 30 min
- Magnesium (if < 0.75 mmol/L): 0.2 ml/kg 50% MgSO4 over 30 min
- Phosphate (if < 0.7 mmol/L): 0.2 mmol/kg of NaPO4 over 30 min 4
Special Considerations
Metformin-Associated Lactic Acidosis (MALA)
- Characterized by elevated blood lactate (>5 mmol/L), anion gap acidosis, and metformin plasma levels generally >5 mcg/mL
- Risk factors: renal impairment, elderly patients, dehydration, contrast studies, surgery
- Management:
Monitoring and Follow-up
- Serial lactate measurements (every 4-6 hours)
- Monitor arterial blood gases, plasma osmolarity, hemodynamics
- Assess lactate clearance (failure to clear within 6 hours associated with increased mortality)
- Monitor electrolytes and renal function 1
Common Pitfalls and Caveats
Delayed recognition of the underlying cause: Prompt identification and treatment of the underlying cause is crucial for improving outcomes 6
Overreliance on bicarbonate therapy: Sodium bicarbonate administration does not improve cardiovascular function or reduce mortality in severe lactic acidosis and may worsen intracellular acidosis 3, 7
Failure to consider hemodialysis early: For severe or medication-induced lactic acidosis (particularly MALA), early hemodialysis can be life-saving 2, 5
Inadequate monitoring: Regular assessment of lactate levels, acid-base status, and electrolytes is essential to guide therapy 1
Continuing medications that contribute to lactic acidosis: Failure to promptly discontinue medications like metformin in high-risk situations (renal impairment, dehydration) 2
Neglecting metabolic derangements: Hypoglycemia, electrolyte abnormalities, and other metabolic disturbances should be corrected 4, 1